Perioperative Nivolumab in Resectable Lung Cancer.

Bibliographic Details
Title: Perioperative Nivolumab in Resectable Lung Cancer.
Authors: Cascone, T.1, tcascone@mdanderson.org, Awad, M. M.2, Spicer, J. D.3, He, J.4, Lu, S.5, Sepesi, B.1, Tanaka, F.6, Taube, J. M.7, Cornelissen, R.8, Havel, L.9, Karaseva, N.10, Kuzdzal, J.11, Petruzelka, L. B.12, Wu, L.13, Pujol, J.-L.14, Ito, H.15, Ciuleanu, T.-E.16, de Oliveira Muniz Koch, L.17, Janssens, A.18, Alexandru, A.19
Source: New England Journal of Medicine; 5/16/2024, Vol. 390 Issue 19, p1756-1769, 14p
Database: General Science Full Text (H.W. Wilson)
More Details
ISSN:00284793
DOI:10.1056/NEJM0a2311926
Published in:New England Journal of Medicine
Language:English